Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kronos Bio (KRON)
NASDAQ:KRON
Kronos Bio (KRON) Ownership - Who Owns Kronos Bio?
163 Followers
Kronos Bio (KRON) Ownership Overview
51.09% Insiders
13.44% Mutual Funds
24.79% Other Institutional Investors
10.68% Public Companies and
Individual Investors
The ownership structure of Kronos Bio (KRON) stock is a mix of institutional, retail and individual investors. Approximately 38.23% of the company’s stock is owned by Institutional Investors, 51.09% is owned by Insiders and 10.68% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 23, 2024 | Elizabeth Olek Sr Vp, Clinical Science | Sold | $7736 |
| Feb 23, 2024 | Frisbee Allison Sr Vp, Corp Operations & Legal | Sold | $12710 |
| Feb 23, 2024 | Lin Charles Y Sr Vp, Research & Development | Sold | $12638 |
| Jan 05, 2024 | Sold | $8692 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | Sold | $1242625 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,878,413 | Institution | 3.13% | 1,915,981 | |
| 1,811,200 | Institution | 3.01% | 1,847,424 | |
| 1,752,745 | Institution | 2.92% | 1,787,800 | |
| 1,630,495 | Institution | 2.71% | 1,663,105 | |
| 1,490,593 | Institution | 2.48% | 1,520,405 | |
| 1,297,959 | Institution | 2.16% | 1,323,918 | |
| 955,866 | Institution | 1.59% | 974,983 | |
| 419,310 | Institution | 0.70% | 427,696 | |
| 365,200 | Institution | 0.61% | 372,504 | |
| 351,602 | Institution | 0.59% | 358,634 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,811,200 | Institution | 3.01% | 1,847,424 | |
| 1,630,495 | Institution | 2.71% | 1,663,105 | |
| 1,490,593 | Institution | 2.48% | 1,520,405 | |
| 419,310 | Institution | 0.70% | 427,696 | |
| 365,200 | Institution | 0.61% | 372,504 | |
| 351,602 | Institution | 0.59% | 358,634 | |
| 293,675 | Institution | 0.49% | 299,549 | |
| 230,052 | Institution | 0.38% | 234,653 | |
| 219,655 | Institution | 0.37% | 224,048 | |
| 161,656 | Institution | 0.27% | 164,889 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,318,872 | Institution | 2.19% | 1,358,438 | |
| 559,541 | Institution | 0.93% | 576,327 | |
| 93,319 | Institution | 0.16% | 91,621 | |
| 3,000 | Institution | <0.01% | 5,970 | |
| 2,981 | Institution | <0.01% | 2,927 | |
| 80 | Institution | <0.01% | 132 |
FAQ
Who Owns Kronos Bio (KRON)?
According to the latest TipRanks data, approximately 24.79% of the company's stock is held by institutional investors, 51.09% is held by insiders, and 10.68% is held by retail investors.
What percentage of Kronos Bio (KRON) stock is held by institutional investors?
According to the latest TipRanks data, approximately 24.79% of Kronos Bio (KRON) stock is held by institutional investors.
What percentage of Kronos Bio (KRON) stock is held by retail investors?
According to the latest TipRanks data, approximately 10.68% of Kronos Bio (KRON) stock is held by retail investors.
Who owns the most shares of Kronos Bio (KRON)?
Vanguard owns the most shares of Kronos Bio (KRON).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.